PepGen Inc

For the period ended Dec 31, 2024. Filed Feb 24, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 24, 2025

PEPG$4.61+92.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity

(IN THOUSANDS, EXCEPT SHARE AMOUNTS)

Common Stock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · TotalStockholders’Equity
Shares · Amount
Balance as of December 31, 2022	23,713,196	$2	$282,566	$(81)	$(102,856)	$179,631
Issuance of stock under the employee stock purchase plan	9,694	—	40	—	—	40
Exercise of stock options	100,351	—	213	—	—	213
Stock-based compensation expense	—	—	7,048	—	—	7,048
Unrealized gain on marketable securities	—	—	—	11	—	11
Cumulative translation adjustment arising during the period	—	—	—	104	—	104
Net loss	—	—	—	—	(78,626)	(78,626)
Balance as of December 31, 2023	23,823,241	$2	$289,867	$34	$(181,482)	$108,421
Issuance of stock in public offering, net of underwriters' fees and issuance costs of $3,730	7,530,000	1	76,351	—	—	76,352
Issuance of common stock from At-the-Market Sales Agreement, net of underwriters' fees of $100	1,000,000	—	9,900	—	—	9,900
Issuance of stock under the employee stock purchase plan	56,540	—	252	—	—	252
Exercise of stock options	209,882	—	2,230	—	—	2,230
Stock-based compensation expense	—	—	11,457	—	—	11,457
Unrealized gain on marketable securities	—	—	—	39	—	39
Cumulative translation adjustment arising during the period	—	—	—	(50)	—	(50)
Net loss	—	—	—	—	(89,981)	(89,981)
Balance as of December 31, 2024	32,619,663	$3	$390,057	$23	$(271,463)	$118,620

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.